Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
TransMedics Group (TMDX) Stock Price & Analysis
529 Followers
TMDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$36.42 - $137.59
Previous Close$136.14
Volume620.34K
Average Volume (3M)959.53K
Market Cap
$4.48B
Enterprise Value$4.65B
Total Cash (Recent Filing)$350.20M
Total Debt (Recent Filing)$516.22M
Price to Earnings (P/E)-399.7
Beta1.34
Next Earnings
Aug 01, 2024EPS Estimate
$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding32,937,296
10 Day Avg. Volume1,005,999
30 Day Avg. Volume959,528
Standard Deviation0.25
R-Squared0.15
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)30.05
Price to Sales (P/S)46.30
Price to Cash Flow (P/CF)-317.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.66
Enterprise Value/Gross Profit23.18
Enterprise Value/Ebitda501.90
Forecast
1Y Price Target
$119.00Price Target Upside-11.81% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering6
TransMedics Group News
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceQ1 results comfortably cleared St. targets, with revenue improving 19%.
Financial GuidanceGuidance Was Significantly Increased Yet Still Looks Conservative.
Operational EfficiencyThe new command center has significantly reduced the time to provide a quote from receiving a transplant request, increasing efficiency in operations.
Bears Say
Financial Growth RateThe company is facing a modest deceleration in growth, moving away from the strong double-digit increases seen in the previous year.
Product DemandHeart transplants declined in the first quarter, indicating a potential area of concern for the company's heart-related Organ Care System.
Trend AnalysisThe company is showing sustained growth in liver transplants but experiencing a contraction in heart and lung transplant volumes, which could signal diverging trends in its business segments.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TMDX FAQ
What was TransMedics Group Inc’s price range in the past 12 months?
TransMedics Group Inc lowest stock price was $36.42 and its highest was $137.59 in the past 12 months.
What is TransMedics Group Inc’s market cap?
Currently, no data Available
When is TransMedics Group Inc’s upcoming earnings report date?
TransMedics Group Inc’s upcoming earnings report date is Aug 01, 2024 which is in 77 days.
How were TransMedics Group Inc’s earnings last quarter?
TransMedics Group Inc released its earnings results on Apr 30, 2024. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of -$0.017 by $0.367.
Is TransMedics Group Inc overvalued?
According to Wall Street analysts TransMedics Group Inc’s price is currently Overvalued.
Does TransMedics Group Inc pay dividends?
TransMedics Group Inc does not currently pay dividends.
What is TransMedics Group Inc’s EPS estimate?
TransMedics Group Inc’s EPS estimate is $0.21.
How many shares outstanding does TransMedics Group Inc have?
TransMedics Group Inc has 32,937,298 shares outstanding.
What happened to TransMedics Group Inc’s price movement after its last earnings report?
TransMedics Group Inc reported an EPS of $0.35 in its last earnings report, beating expectations of -$0.017. Following the earnings report the stock price went up 24.934%.
Which hedge fund is a major shareholder of TransMedics Group Inc?
Among the largest hedge funds holding TransMedics Group Inc’s share is Driehaus Capital Management LLC. It holds TransMedics Group Inc’s shares valued at 81M.
---
TransMedics Group Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$119.00 (-11.81% Downside)
$119.00 (-11.81% Downside)
Blogger Sentiment
Bullish
TMDX Sentiment 92%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 37.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 18.4%
Last 30 Days ▲ 18.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.61%
12-Months-Change
Fundamentals
Return on Equity
-5.79%
Trailing 12-Months
Asset Growth
152.13%
Trailing 12-Months
Company Description
TransMedics Group Inc
TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.
---
TMDX Earnings Call
Q1 2024
0:00 / 0:00
---
TMDX Stock 12 Month Forecast
Average Price Target
$119.00
▼(-11.81% Downside)
Technical Analysis
Best Analysts Covering TMDX
1 Year
1 Year Success Rate
19/21 ratings generated profit
1 Year Average Return
+63.93%
reiterated a buy rating 16 days ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +63.93% per trade.
---